http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0013599-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2527d4b107947bda166630aca8cfced4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1233
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-06
filingDate 1999-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68974d1b6bf4a46020be21fac5634359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e2923cf1083ff6e92ae0673c99792d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ae3c785967936406828639b27cdda71
publicationDate 2000-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0013599-A1
titleOfInvention Systems and methods for ablating discrete motor nerve regions
abstract The present invention is systems, and methods for ablating motor nerve tissue by inserting an operative element (28) connectible to an ablation energy generator (40) into a defined percutaneous tissue region. The systems and methods apply stimulant energy in the defined percutaneous tissue region to stimulate targeted motor nerve tissue prior to ablation by the operative element. Application of the nerve ablation energy can permanently eliminate the function of a targeted motor nerve branch, to thereby inactivate a selected muscle. The muscle inactivation may, e.g., treat dystonia, other hyper-function neuromuscular dysfunctions in the face, the neck such as torticollis, blepharospasm, and uncontrolled grimacing. The muscle inactivation may also provide cosmetic results to eliminate or prevent aesthetically displeasing skin furrows, frowning, wrinkles, or neck bands, which can arise from normal muscle contraction or prolonged exposure of the face to the sun.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009124726-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10441344-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103813745-A
priorityDate 1998-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5161533-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5714468-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID52152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID52152

Total number of triples: 33.